Get to Know Dr. Richard Kradin
Pathologist Dr. Richard Kradin at Massachusetts General Hospital is a former associate professor at Harvard Medical School and a specialist in the often-overlooked science of mind/body healing.
He is trained in internal medicine, immunology and pathology. His multidisciplinary interests include thoracic diseases such as malignant pleural mesothelioma. He has treated dyspnea, interstitial lung diseases, kidney cancer and pulmonary fibrosis.
Kradin has contributed to more than 200 medical articles and book chapters on a wide variety of topics, including the effects of placebos on the healing process.
In 2019, he co-authored an article on two case studies for the American Journal of Industrial Medicine that detailed the increased susceptibility to mesothelioma cancer for those with Lynch Syndrome.
Kradin also co-authored a paper about the diagnostic and pathological growth of pleural mesothelioma case reports from a historical perspective, dating back to 1930.
He often lectures his peers about taking more seriously the relationship between physical and mental sciences, believing strongly in the totality of the human condition.
Specialties of Dr. Richard Kradin
- Thoracic disease
- Lung cancer
- Internal medicine
Dr. Richard Kradin’s Experience and Medical Education
- Massachusetts General Hospital
- Pennsylvania Hospital (Residency)
- Thomas Jefferson University (M.D.)
- London School of Hygiene and Tropical Medicine, University of London
- CG Jung Institute, Boston
- Boston Institute for Psychotherapy
Award and Certifications
- American Board of Internal Medicine, Pulmonary Disease
- American Board of Pathology
- Gravida Award, American Board of Pathology
- Harvard Medical School, Mind Body Science co-director
Publications of Dr. Richard Kradin
- Shih, A.R. & Kradin, R.L. (2019, April). Malignant mesothelioma in Lynch syndrome: A report of two cases and a review of the literature. American Journal of Industrial Medicine.
- Kradin, R. (2017, June 20). Diagnostic Pathology of Infectious Disease, 2nd Edition. Elsevier.
- Mark, E.J. & Kradin, R.L. (2006, February). Pathological recognition of diffuse malignant mesothelioma of the pleura: the significance of the historical perspective as regards this signal tumor. Seminars In Diagnostic Pathology.
Thank you for your feedback. Would you like to speak with a Patient Advocate?